Price
$406.86+31.57%Social Signal Score
Analyst Ratings
37 analystsRevenue
$1.77B+181.02%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Udit Batra
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 15,000
- Beta
- 1.15
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 3.62
Financials
Revenue
$1.77B+181.0%Net Income
$81.00M-53.5%EBITDA
$427.00M+78.8%Free Cash Flow
$55.00M-63.4%EPS (diluted)
$0.82-61.9%Shares Outstanding (diluted)
98.65M+21.9%Operating Expenses
$504.00MCash & Debt
$593.00MReturn of Capital
$1.00MRevenue by Segment (annual)
$3.17BDividend per Share
$0.04Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.17B | $642.63M | $10.80 |
| 2024 | $2.96B | $637.83M | $10.75 |
| 2023 | $2.96B | $642.23M | $10.87 |
| 2022 | $2.97B | $707.75M | $11.80 |
| 2021 | $2.79B | $692.84M | $11.25 |
| 2020 | $2.37B | $521.57M | $8.40 |
| 2019 | $2.41B | $592.20M | $8.76 |
| 2018 | $2.42B | $593.79M | $7.71 |
| 2017 | $2.31B | $20.31M | $0.25 |
| 2016 | $2.17B | $521.50M | $6.46 |
| 2015 | $2.04B | $469.05M | $5.70 |
| 2014 | $1.99B | $431.62M | $5.12 |
| 2013 | $1.90B | $450.00M | $5.27 |
| 2012 | $1.84B | $461.44M | $5.25 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from WAT's reported EPS growth of 5.7% a year over 13 years.
- EPS in 5 years
- $14.25
- Implied price
- $498.68
- Return from $476.70
- 0.9% a year
To earn 15.0% a year on these assumptions you'd need to buy at $247.93 — -48.0% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 25 | 30 | 35 | 40 | 45 |
|---|---|---|---|---|---|
| -4.3% | -14.6% | -11.4% | -8.6% | -6.2% | -3.9% |
| 0.7% | -10.1% | -6.8% | -3.9% | -1.3% | 1.1% |
| 5.7% | -5.7% | -2.2% | 0.9% | 3.6% | 6.1% |
| 10.7% | -1.2% | 2.5% | 5.7% | 8.5% | 11.1% |
| 15.7% | 3.3% | 7.1% | 10.5% | 13.4% | 16.1% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+40.00%Social Signal Score
Mentions (42)
- Newsdefenseworld.net·1d ago·Positive
Water Stocks Worth Watching – November 19th Coca-Cola, Waters, Ecolab, Pentair, Xylem, American Water Works, and IDEXX Laboratories are the seven Water stocks to watch today, according to MarketBeat's stock screener tool. Water stocks are shares in publicly traded companies involved in supplying, treating, or managing water, such as water utilities and firms that make pipes, pumps, or filtration systems. They give
View source ↗ - News (Marketaux)insidermonkey.com·2d ago·Positive
Waters Corporation (WAT): Position Exited Above Fair Value Waters Corporation (WAT): Position Exited Above Fair Value
View source ↗ - 4chan /biz/biz·2d ago·Neutral
WAT SHOULD I DO WITH SEMI STOCKS HOLD TO 0?????? THIS CANT BE HAPPENING MU 1500 SNDK 3000
View source ↗ - Newsprnewswire.com·5d ago·Neutral
Waters Corporation to Present at the 9th Annual Evercore Healthcare Conference MILFORD, Mass., Nov. 17, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
View source ↗ - Newsseekingalpha.com·5d ago·Neutral
International Seaways: Even After Some Rough Waters, INSW Is Still A Buy I rate International Seaways a Buy: my $123.56 dividend-discount valuation implies 17.4% upside from $105.23. INSW's spot exposure captures elevated tanker rates amid persistent regional shipping risks; reserve replenishment and limited fleet replacement should support demand. My valuation assumes 2027 EPS of $13.34, 2028 EPS of $10.67, and an 85% dividend payout, above historical aggregate payouts.
View source ↗ - News (RSS)zerohedge·17d ago·Negative
…o Market Structure Bill With A Bigger SEC Role After Sweep Authored by Micah Zimmerman via Bitcoin Magazine,House Democrats are discussing a plan to turn Rep. Maxine Waters' Crypto Investor and Consumer Bill of Rights into their own crypto market structure bill next Congress, with ideas that include a bigger role for the SEC and a smaller one for the CFTC, Eleanor Terrett reported Wednesday.🚨SCOOP: House Democrats are discussing plans to expand the Crypto Investor and Consumer Bill of Rights, @…
View source ↗ - Newsmarketbeat.com·18d ago·Negative
Waters Q3 Earnings Call Highlights Waters NYSE: WAT reported third-quarter 2026 revenue of $1.767 billion and adjusted earnings per share of $4.10, as the company cited double-digit organic growth, improving performance in acquired businesses and cost actions that supported profitability.
View source ↗ - News (RSS)seekingalpha·19d ago·Positive
Waters Corporation (WAT) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·19d ago·Positive
Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance Raised WAT beats Q3 2026 earnings and revenue estimates, fueled by acquisitions and strong organic growth and raises its full-year revenue and earnings outlook.
View source ↗ - Newsseekingalpha.com·19d ago·Positive
Waters Corporation (WAT) Q3 2026 Earnings Call Transcript Waters Corporation (WAT) Q3 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·19d ago·Neutral
Waters (WAT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates The headline numbers for Waters (WAT) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
View source ↗ - Newszacks.com·19d ago·Positive
Waters (WAT) Beats Q3 Earnings and Revenue Estimates Waters (WAT) came out with quarterly earnings of $4.1 per share, beating the Zacks Consensus Estimate of $3.99 per share. This compares to earnings of $3.4 per share a year ago.
View source ↗ - Newsprnewswire.com·19d ago·Negative
Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highlights Total reported revenue of $1.767 billion exceeded guidance midpoint by $14 million, led by organic revenue growth of 9% as reported and 10% in constant currency, with acquired business revenue landing slightly ahead of guidance. GAAP EPS of $0.82; Adjusted EPS of $4.10 grew 21% and exceeded guidance.
View source ↗ - Newsprnewswire.com·19d ago·Neutral
Waters Acquires MOBILion Systems, Bringing Advanced Ion-Mobility Separation to its Mass Spectrometry Portfolio with the Speed and Resolution AI Workflows Require for Proteomics Biomarker Discovery Adds MOBILion's breakthrough SLIM high-resolution ion mobility technology, which separates molecules by size, shape and charge in milliseconds, complementing Waters' industry leading mass spectrometry platform, transforming samples to insights. Accelerates Waters' move into proteomics with research cap…
View source ↗ - News (RSS)fortune·25d ago·Negative
Waters’ new AI tool targets one of the pharmaceutical industry’s most tedious tasks Waters took one-and-a-half years to develop its new AI tool, which it says will cut manual drug-testing work performed by scientists by 95%.
View source ↗ - Newsprnewswire.com·25d ago·Neutral
…protected customer data resides, with no compromise to integrity, traceability, or compliance MILFORD, Mass., Oct. 28, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine learning, and automation cloud-based capabilities directly into Empower Software, the chromatography data system of record for regulated laboratories worldwide.
View source ↗ - Newszacks.com·26d ago·Neutral
Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests WAT partners with Labcorp to expand access to FDA-approved HPV testing by late 2026, potentially boosting diagnostics adoption and cervical cancer screening.
View source ↗ - Newsprnewswire.com·30d ago·Neutral
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026 Labcorp intends to be the first commercial laboratory to offer FDA-approved HPV testing with the BD Onclarity™ HPV Assay across clinician-collected and self-collected screening options in clinic, patient service center, and at-home settings Through a network serving more than 850,000 physicians and healthcare providers and more than 2,200 patient ser…
View source ↗ - Newsinvezz.com·34d ago·Positive
Two stocks poised to benefit from rotation out of AI Investors looking beyond artificial intelligence (AI) should closely watch two healthcare names – Thermo Fisher Scientific (TMO) and Waters (WAT) – according to Josh Brown. In his latest report, the Ritholtz' chief executive highlighted laboratory equipment suppliers whose improving businesses are attracting buyers as tech stocks face pressure.
View source ↗ - News (RSS)seekingalpha·34d ago·Positive
Brunswick Keeps Navigating Tough Waters (Rating Upgrade)
View source ↗ - News (RSS)investing·40d ago·Neutral
Waters launches AI Link software for lab automation
View source ↗ - Newsdefenseworld.net·43d ago·Positive
Best Water Stocks To Keep An Eye On – October 8th CocaCola, Waters, and NuScale Power are the three Water stocks to watch today, according to MarketBeat's stock screener tool. Water stocks are shares of publicly traded companies involved in supplying, treating, distributing, or managing water, including utilities, infrastructure firms, and water-technology companies. Investors may view them as opportunities to benefit from essential demand and water
View source ↗ - Newszacks.com·45d ago·Neutral
Here's Why You Should Retain WAT Stock in Your Portfolio for Now Waters' growth outlook is fueled by strong analytical sciences demand, BD synergies and innovation, even as China weakness and integration risks persist.
View source ↗ - Newsdefenseworld.net·49d ago·Positive
Water Stocks To Research – October 3rd CocaCola, Ecolab, American Water Works, Waters, Xylem, NuScale Power, and Veralto are the seven Water stocks to watch today, according to MarketBeat's stock screener tool. Water stocks are shares of publicly traded companies involved in water utilities, treatment, infrastructure, equipment, or conservation technologies. Investors may consider them a way to gain exposure to demand for
View source ↗ - Newsprnewswire.com·52d ago·Neutral
Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call MILFORD, Mass., Oct. 1, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q3 2026 financial results conference call on Tuesday, November 3, 2026, at 8:00 a.m.
View source ↗ - Newsmarketbeat.com·57d ago·Negative
Waters Tops Growth Outlook as AI Demand, BD Integration Fuel Momentum Waters NYSE: WAT President and Chief Executive Officer Udit Batra said the company's second-quarter performance exceeded expectations, supported by broad-based growth in its legacy analytical-science operations and early progress integrating acquired Becton Dickinson businesses.
View source ↗ - News (RSS)investing·59d ago·Neutral
Waters Corporation stock hits all-time high at 433.09 USD
View source ↗ - Newsseekingalpha.com·60d ago·Positive
Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript Waters Corporation (WAT) Presents at U.S. All Stars Conference Transcript
View source ↗ - Newszacks.com·61d ago·Neutral
Still Waters Bring Mixed Pre-Market Levels A grand total of zero monthly or quarterly economic reports have come out so far this week.
View source ↗ - Newszacks.com·65d ago·Neutral
Waters Launches BD FACSDiscover A7 for Advanced Flow Cytometry WAT launches the BD FACSDiscover A7 globally, bringing advanced spectral flow cytometry, automation and standardized workflows to research labs.
View source ↗ - Newsprnewswire.com·69d ago·Positive
Waters Sets Benchmark for Standardized Spectral Flow Cytometry with Commercial Launch of BD FACSDiscover A7 Cell Analyzer Enables routine 50+ parameter experiments with BD SpectralFX™ Technology, accelerating breakthrough discoveries in the fight against cancer and other diseases. Minimizes instrument and user differences with first-of-its-kind FACSTruQ™ Technology, achieving industry-leading standardization for greater confidence in results.
View source ↗ - Newsprnewswire.com·72d ago·Neutral
Waters Corporation to Present at the J.P. Morgan U.S. All Stars Conference MILFORD, Mass., Sept. 11, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
View source ↗ - Newsseekingalpha.com·74d ago·Positive
Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript Waters Corporation (WAT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - Newszacks.com·80d ago·Neutral
Why Is Waters (WAT) Up 3.1% Since Last Earnings Report? Waters (WAT) reported earnings 30 days ago. What's next for the stock?
View source ↗ - News (RSS)yahoo·86d ago·Neutral
Is Wall Street Bullish or Bearish on Waters Corporation Stock?
View source ↗ - Newsbenzinga.com·87d ago·Positive
This Waters Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
View source ↗ - Newsprnewswire.com·88d ago·Neutral
Waters Corporation to Present at the Wells Fargo Healthcare Conference MILFORD, Mass., Aug. 26, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D.
View source ↗ - 4chan /biz/biz·92d ago·Negative
wat do with 100k cash and ZERO attatchments? Looking for biz ideas, here is my scenario: 100k cash after selling my self-built tiny (huge) house with tesla battery and solar built in. Fully built diesel BMW X6 Custom ducati monster 24 foot enclosed trailer Spawn in southern california with above assets. WAT DO??
View source ↗ - News (RSS)zerohedge·96d ago·Negative
…tinues to be clear that Washington and Tehran are digging in with their competing maximum demands. Hormuz isn't the only chokepoint still witnessing active conflict. Waters off Yemen and the Red Sea also continue to heat up, with the Iranian-allied Houthi rebels still escalating. According to The Wall Street Journal on Tuesday, the group is "shutting down operations at a strategic seaport and pushing closer to the Bab al-Mandeb Strait, an important global shipping chokepoint." The report cites Y…
View source ↗ - Newsdefenseworld.net·99d ago·Negative
Assetmark Inc. Has $1.57 Million Stake in Waters Corporation $WAT Assetmark Inc. lowered its holdings in Waters Corporation (NYSE: WAT) by 56.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,196 shares of the medical instruments supplier's stock after selling 5,449 shares during the period. Assetmark Inc.'s holdings in Waters were
View source ↗ - Newsmarketbeat.com·105d ago·Negative
Waters Q2 Earnings Call Highlights Waters NYSE: WAT reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business revenue and adjusted earnings per share after results exceeded its prior guidance.
View source ↗ - 4chan /biz/biz·106d ago·Neutral
Snitching on a Crime Family (British Mob) Ernest: Atlantic City. Jacob: Casino Trade. Eugene: Del-Fi Records. Raymond: Detective Comics. Chip: Tavern Keno. Eddie: Internal Medicine. Ted: United Nations. Laura: Federal Bureau of Investigation. Diane: British Airways. Michael: Raytheon. Steven: African Grand Ol' Party. Ellen: Goldman-Sachs. David: National Security Agency. Jack: Central Intelligence Agency. Charles: Waters Foundation.
View source ↗
Earnings
Mon, Feb 8(in 3 months)
Consensus estimate $4.63 per share
Typical surprise +1.4% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Nov 3$4.10 vs $4.00beat
- Tue, Aug 4$3.05 vs $3.01beat
- Tue, May 5$2.70 vs $2.31beat
- Mon, Feb 9$4.53 vs $4.51beat
- Tue, Nov 4$3.40 vs $3.21beat
- Mon, Aug 4$2.95 vs $2.94beat
Estimates and results for WAT via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by WAT officers and directors.
- Bought
- $451k
- Sold
- $1.4m
2 trades
1 trade
- Kuebler Christopher Asold
- Jiang Weibought
- Fearon Richard Hbought
97 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Kevin Hernhouse · OK01 · disclosed Sep 2, 2026 (20d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed May 13, 2026 (30d later)Buy$1,001 - $15,000
- Thomas Keanhouse · NJ07 · disclosed Apr 14, 2026 (35d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Apr 8, 2026 (21d later)Buy$1,001 - $15,000
- Thomas Keanhouse · NJ07 · disclosed Mar 18, 2026 (33d later)Sell$1,001 - $15,000
- Kevin Hernhouse · OK01 · disclosed Mar 6, 2026 (25d later)Sell$1,001 - $15,000
- Debbie Dingellhouse · MI06 · disclosed Feb 24, 2026 (14d later)Sell$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (447d later)Buy$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (36d later)Buy$1,001 - $15,000
- Julia Letlowhouse · LA05 · disclosed Jan 13, 2026 (420d later)Sell$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Oct 10, 2025 (10d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Oct 3, 2025 (4d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Sep 12, 2025 (30d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Sep 12, 2025 (31d later)Buy$1,001 - $15,000
- Gilbert Cisneroshouse · CA31 · disclosed Sep 12, 2025 (17d later)Buy$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (22d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Aug 13, 2025 (28d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Jun 10, 2025 (26d later)Buy$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed May 8, 2025 (30d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Mar 28, 2025 (31d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
